Infections | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Total | cOR (95% CI) | p for trend |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(N = 743) | (N = 2773) | (N = 2789) | (N = 2807) | (N = 3200) | (N = 3200) | (N = 3169) | (N = 1195) | (N = 2003) | (N = 2000) | (N = 23,879) | |||
HIV+ | 4 | 14 | 14 | 6 | 9 | 5 | 1 | 0 | 3 | 2 | 58 | ||
0.54% | 0.50% | 0.50% | 0.21% | 0.28% | 0.16% | 0.03% | 0.00% | 0.15% | 0.10% | 0.24% | 0.76 (0.67–0.85) | 0.00 | |
Syphilis+ | 0 | 23 | 38 | 43 | 25 | 26 | 21 | 7 | 13 | 6 | 202 | ||
0.00% | 0.83% | 1.36% | 1.53% | 0.78% | 0.81% | 0.66% | 0.59% | 0.65% | 0.30% | 0.85% | 0.91 (0.86–0.97) | 0.00 | |
HCV+ | 3 | 6 | 9 | 10 | 6 | 1 | 8 | 1 | 1 | 1 | 46 | ||
0.40% | 0.22% | 0.32% | 0.36% | 0.19% | 0.03% | 0.25% | 0.08% | 0.05% | 0.05% | 0.19% | 0.83 (0.73–0.94) | 0.00 |